Jorquera PA - Search Results

1

Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge.

Powell TJ, Jacobs A, Tang J, Cardenas E, Palath N, Daniels J, Boyd JG, Bergeron HC, Jorquera PA, Tripp RA. Powell TJ, et al. Among authors: jorquera pa. Vaccines (Basel). 2022 Dec 5;10(12):2078. doi: 10.3390/vaccines10122078. Vaccines (Basel). 2022. PMID: 36560488 Free PMC article.

2

Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains.

Choi Y, Mason CS, Jones LP, Crabtree J, Jorquera PA, Tripp RA. Choi Y, et al. Among authors: jorquera pa. Viral Immunol. 2012 Jun;25(3):193-203. doi: 10.1089/vim.2011.0094. Epub 2012 May 2. Viral Immunol. 2012. PMID: 22551066 Free PMC article.

3

A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.

Boyoglu-Barnum S, Gaston KA, Todd SO, Boyoglu C, Chirkova T, Barnum TR, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ. Boyoglu-Barnum S, et al. J Virol. 2013 Oct;87(20):10955-67. doi: 10.1128/JVI.01164-13. Epub 2013 Jul 24. J Virol. 2013. PMID: 23885067 Free PMC article.

4

Advances in and the potential of vaccines for respiratory syncytial virus.

Jorquera PA, Oakley KE, Tripp RA. Jorquera PA, et al. Expert Rev Respir Med. 2013 Aug;7(4):411-27. doi: 10.1586/17476348.2013.814409. Expert Rev Respir Med. 2013. PMID: 23964629 Review.

5

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.

Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA. Jorquera PA, et al. PLoS One. 2013 Sep 10;8(9):e74905. doi: 10.1371/journal.pone.0074905. eCollection 2013. PLoS One. 2013. PMID: 24040360 Free PMC article.

6

Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.

Boyoglu-Barnum S, Chirkova T, Todd SO, Barnum TR, Gaston KA, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ. Boyoglu-Barnum S, et al. J Virol. 2014 Sep;88(18):10569-83. doi: 10.1128/JVI.01503-14. Epub 2014 Jul 2. J Virol. 2014. PMID: 24990999 Free PMC article.

7

Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease.

Jorquera PA, Oakley KE, Powell TJ, Palath N, Boyd JG, Tripp RA. Jorquera PA, et al. Vaccines (Basel). 2015 Oct 12;3(4):829-49. doi: 10.3390/vaccines3040829. Vaccines (Basel). 2015. PMID: 26473935 Free PMC article.

8

Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.

Jorquera PA, Anderson L, Tripp RA. Jorquera PA, et al. Expert Rev Vaccines. 2016;15(2):173-87. doi: 10.1586/14760584.2016.1115353. Epub 2015 Dec 5. Expert Rev Vaccines. 2016. PMID: 26641318 Review.

9

MicroRNA-555 has potent antiviral properties against poliovirus.

Shim BS, Wu W, Kyriakis CS, Bakre A, Jorquera PA, Perwitasari O, Tripp RA. Shim BS, et al. Among authors: jorquera pa. J Gen Virol. 2016 Mar;97(3):659-668. doi: 10.1099/jgv.0.000372. Epub 2015 Dec 18. J Gen Virol. 2016. PMID: 26683768

10

Human Respiratory Syncytial Virus: An Introduction.

Jorquera PA, Anderson L, Tripp RA. Jorquera PA, et al. Methods Mol Biol. 2016;1442:1-12. doi: 10.1007/978-1-4939-3687-8_1. Methods Mol Biol. 2016. PMID: 27464683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page